Warning! The use of Bextra has been linked to an increased rate of heart attacks, strokes, blood clots, and even death.

Recent reports in the media regarding the dangers of COX-2 inhibitors have raised concerns over Bextra, and the cardiovascular problems that can occur with its usage. Bextra is a non-steroidal anti-inflammatory medication that targets the enzyme COX-2 to relieve the stiffness, pain, and inflammation associated with osteoarthritis and adult rheumatoid arthritis. It was recalled by the FDA on April 7, 2005 due to increased risk or a fatal connection to heart attacks, strokes, and adverse skin reactions, including blistering, sores, swelling, cough, and fever. Bextra has been linked with other medications in the COX-2 family: Celebrex and Vioxx. Vioxx has been withdrawn from the market and Celebrex carries a black box warning.

If you or a loved one has been injured or have experienced any of the symptoms listed above while taking Bextra, please submit the accompanying form. You may be entitled to monetary awards for your injury!